Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs
Study Details
Study Description
Brief Summary
This study is about the current knowledge on the immunological changes observed in various healthcare workers in this part of the world, who remained asymptomatic while working in high exposure areas of COVID-19 infection.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Coronaviruses (CoVs) are enveloped, single positive-strand RNA viruses belonging to the large subfamily Coronavirinae, which can infect mammals and several other animals.The continued spread of coronavirus disease 2019 (COVID-19) has prompted widespread concern around the world, and the World Health Organization (WHO), on 11 March 2020, declared COVID-19 a pandemic. Studies on severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) showed that virus-specific antibodies were detectable in 80-100% of patients at 2 weeks after symptom onset. Currently, the antibody responses against SARS-CoV-2 remain poorly understood and the clinical utility of serological testing is unclear. Little is known about the kinetics, tissue distribution, cross-reactivity and neutralization antibody response in COVID-19 patients. Asymptomatic cases are common but to date there are scarce epidemiological surveys that provide a clear percentage of asymptomatic cases.
A large number of healthcare workers have been infected with the virus worldwide, presenting with severe symptoms to no symptoms at all, in which case being diagnosed on contact tracing only. The seropositivity rate in previously undiagnosed healthcare workers has been reported in different regions of the world. In a combined study of three hospitals of Turkey, the seropositivity rate of the previously undiagnosed HCWs was 2.7%. A study done in China revealed 17.5 % seropositivity rate.
This study will aim to comprehensively review the current knowledge on the immunological changes observed in various healthcare workers in this part of the world, who remained asymptomatic while working in high exposure areas of COVID-19 infection.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Asymptomatic frontline HCWs for COVID 19 All healthcare workers who worked in high exposure areas of hospital dealing with COVID 19. |
Diagnostic Test: IgG SARS CoV 2 antibodies
The asymptomatic healthcare workers of high exposure COVID19 areas will be tested for IgG SARS CoV 2 antibodies
|
Outcome Measures
Primary Outcome Measures
- SARS CoV 2 IgG antibodies [3 months]
The presence or absence of SARS CoV 2 antibodies in serum of HCWs
Eligibility Criteria
Criteria
Inclusion Criteria:
- All HCWs who had been working in high exposure areas of COVID 19
Exclusion Criteria:
- Any HCW of high exposure areas of COVID 19 who suffered from COVID 19 themselves diagnosed on PCR or clinically
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Lahore General Hospital | Lahore | Punjab | Pakistan | 54500 |
Sponsors and Collaborators
- Lahore General Hospital
Investigators
- Principal Investigator: Amina Asif, MPhilMicro, LahoreGeneralHospital.Lahore
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- LGH002